BUNKER KEVIN D. (Chief Operating Officer) sold 1.2% of their position (10.31K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $207.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/14/2023ACC: 0001725160-23-000031
Officer· Chief Operating Officer
Since Apr 2020
-10.31K
Net shares
Net seller
$207.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10.31K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−3.81K
Price / share
$20.42
Trade value
$77.76K
% of position
0.4%
2/13/2023
875.46K→871.66K
Common Stock
Direct
Shares
−6.50K
Price / share
$19.98
Trade value
$129.87K
% of position
0.7%
2/14/2023
871.66K→865.16K
Total
Net shares
−10.31K
Net value
-$207.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2023 | S · Sale | −3.81K | $20.42 | $77.76K | 0.4% | 875.46K | 871.66K |
| Common Stock Direct | 2/14/2023 | S · Sale | −6.50K | $19.98 | $129.87K | 0.7% | 871.66K | 865.16K |
| Total | −10.31K | -$207.63K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned95K
Common Stock
IndirectShares owned350.00
Total
95.35K indirect95.35K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 95K | Indirect |
| Common Stock | 350.00 | Indirect |
| Total | 95.35K | 95.35K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported